Latest

Health

Featured Neuroscience Open Neuroscience Articles

·March 17, 2020·3 min read

Coronavirus stable for hours on surfaces: What you need to know

SARS-CoV-2 is detectable in aerosols for up to three hours and up to four hours on copper. On cardboard, the virus is detectable for up to 24 hours, and up to three days on plastic and stainless steel. The study suggests the virus may be acquired through the air in addition to touching surfaces.

Featured Neuroscience Open Neuroscience Articles

·March 17, 2020·3 min read

Injury to the nose increases risk of bacteria entering the brain

Damage to the nasal epithelium increases the risk of bacteria entering into the brain, potentially resulting in long-term health problems.

Featured Neuroscience Open Neuroscience Articles

·March 17, 2020·3 min read

COVID-19: The immune system can fight back

Australian researchers have mapped immune responses from one of the country's first COVID-19 patients. The findings shed light on how the immune system fights the virus and assists in recovery from the virus.

Featured Neuroscience

·March 16, 2020·4 min read

COVID-19 test debacle: ‘We hoped it would go away before it reached us’

Researchers who have been studying the coronavirus since the outbreak say the US had an opportunity to be well ahead of the game when it came to COVID-19. However, problems with testing rollouts, regulatory guidelines, and initial flaws in early CDC tests, has left US citizens in critical danger. Rather than focusing on reacting to the pandemic, researchers say we should have focused on preparedness.

Featured Neuroscience

·March 16, 2020·5 min read

Designing a coronavirus vaccine: Researchers prepare for next year and beyond

Researchers are making progress in developing potential vaccines for coronavirus infections. While a vaccine for COVID-19 might be over a year away from market, researchers are looking ahead to attempt to prevent future outbreaks.

This shows a man in an empty parking lot

Featured Neuroscience

·March 16, 2020·4 min read

COVID-19 ‘Worry about 4 weeks from now,’ researchers warn

With the peak of COVID-19 cases occurring between 3.5 to four weeks after controlled interventions were put into place in China, US researchers are urging the public to ramp up social distancing efforts and increase testing immediately.

Featured Neuroscience

·March 16, 2020·8 min read

NIH Clinical Trial of Investigational Vaccine for COVID-19 Begins

A phase 1 trial evaluating an investigational vaccine designed to protect against COVID-19 has begun in Seattle. The study will enroll 45 healthy people aged 18 to 55, over approximately 6 weeks. The first participant received the investigational vaccine today. Adults in the Seattle area may join the study.

Featured Neuroscience Open Neuroscience Articles

·March 15, 2020·3 min read

Antibodies from COVID-19 survivors could be used to treat patients and protect those at risk

Johns Hopkins University researchers propose using antibodies from the plasma or serum of those who have recovered from COVID-19 to help boost the immunity of newly infected patients and for those at risk of contracting the disease. Researchers say the antibodies may bind to and neutralize SARS-CoV-2. The technique has been proven successful in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic.

Featured Neuroscience Psychology

·March 14, 2020·5 min read

How chronic stress changes the brain, and what you can do to reverse the damage

Chronic stress can affect a person's health and mental well being. Due to the COVID-19 virus, chronic stress is on the rise worldwide. Researchers examine the general and psychological health implications of chronic stress and suggest some methods we can adopt to keep our stress levels in check.

Featured Neuroscience

·March 13, 2020·3 min read

Coronavirus spreads quickly and sometimes before people have symptoms

The time between cases in a chain of transmission of COVID-19 is less than one week, and more than 10% of patients are infected by someone who has the virus but is not yet symptomatic.

Featured Neuroscience Open Neuroscience Articles

·March 13, 2020·5 min read

Potential treatment for Lyme disease kills bacteria that may cause lingering symptoms

Mouse study reveals the antibiotic azlocillin completely kills off the Borrelia burgdorferi bacteria at the onset of Lyme disease. Findings also suggest the drug could be effective for treating patients infected with drug-tolerant bacteria that may cause lingering symptoms.

Featured Genetics Neuroscience

·March 13, 2020·7 min read

New COVID-19 diagnostic test could deliver results in less than 30 minutes

MIT researchers are working on a range of projects to help diagnose and slow the transmission of COVID-19. Researchers report they are developing a paper-based COVI-19 test that can deliver results within less than 30 minutes. They are currently submitting to the FDA for emergency use authorization, which would grant temporary approval for using the test on patient samples during public health emergencies. Another research team report they have developed an experimental RNA vaccine that is ready to test.